Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $853.86 billion, total revenue of $173.15 billion and a weighted average PE ratio of 47.56.
Market Cap
853.86B
Revenue
173.15B
Profits
17.95B
PE Ratio
47.56
Profit Margin
10.37%
Dividend Yield
0.20%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 230.05B | -1.35% | 1,016,589 | 46.34B |
| 2 | DHR | Danaher Corporation | 151.89B | 0.18% | 2,859,961 | 25.11B |
| 3 | NTRA | Natera, Inc. | 47.03B | -3.67% | 833,492 | 2.71B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 43.72B | 1.82% | 340,976 | 4.55B |
| 5 | A | Agilent Technologies, Inc. | 43.38B | -2.44% | 2,966,161 | 7.37B |
| 6 | IQV | IQVIA Holdings Inc. | 43.08B | -0.24% | 1,842,151 | 16.98B |
| 7 | WAT | Waters Corporation | 40.74B | -1.56% | 435,137 | 4.64B |
| 8 | ILMN | Illumina, Inc. | 32.55B | -5.31% | 1,791,268 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 28.02B | -0.63% | 202,022 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 27.18B | -0.21% | 456,546 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 26.79B | -0.76% | 639,935 | 11.56B |
| 12 | GH | Guardant Health, Inc. | 21.67B | -4.17% | 1,821,580 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.77B | -1.79% | 186,915 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 14.37B | -0.70% | 1,576,273 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.92B | -1.66% | 659,834 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 13.12B | 0.18% | 314,539 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 8.92B | -1.44% | 1,376,585 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 8.87B | -7.66% | 1,380,549 | 431.80M |
| 19 | RDNT | RadNet, Inc. | 5.87B | -1.00% | 471,611 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.50B | -1.08% | 1,388,561 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.40B | -2.01% | 423,070 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.02B | -4.73% | 1,508,870 | 308.08M |
| 23 | GRAL | GRAIL, Inc. | 3.57B | -3.03% | 658,334 | 165.26M |
| 24 | VCYT | Veracyte, Inc. | 3.48B | -4.22% | 1,684,139 | 561.90M |
| 25 | CDNA | CareDx, Inc. | 2.58B | -4.91% | 1,178,533 | 458.09M |
| 26 | WGS | GeneDx Holdings Corp. | 2.57B | -3.26% | 435,337 | 454.43M |
| 27 | NEO | NeoGenomics, Inc. | 2.32B | -3.17% | 1,723,887 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.82B | 1.61% | 2,973,107 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.59B | 6.10% | 1,714,322 | 35.41M |
| 30 | OPK | OPKO Health, Inc. | 1.10B | -1.33% | 2,414,382 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 1.02B | -2.22% | 372,588 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 539.57M | -1.70% | 192,537 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 302.25M | -0.63% | 1,429,692 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 283.09M | -5.79% | 108,315 | 102.94M |
| 35 | XGN | Exagen Inc. | 179.03M | -1.73% | 244,025 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 135.15M | -3.73% | 81,034 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 119.38M | -3.40% | 602,716 | 537.08K |
| 38 | BNR | Burning Rock Biotech Limited | 107.47M | 1.90% | 29,177 | 74.58M |
| 39 | MBAI | Check-Cap Ltd. | 100.63M | 0.15% | 35,020 | - |
| 40 | MDXH | MDxHealth SA | 68.77M | -0.11% | 277,130 | 114.02M |
| 41 | PRPO | Precipio, Inc. | 51.65M | -1.50% | 205,150 | 27.20M |
| 42 | ADVB | Advanced Biomed Inc. | 16.03M | 1.36% | 276,758 | - |
| 43 | XWEL | XWELL, Inc. | 8.68M | 2.00% | 35,483 | 28.28M |
| 44 | NDRA | ENDRA Life Sciences Inc. | 7.51M | -7.49% | 24,474 | - |
| 45 | ISPC | iSpecimen Inc. | 3.88M | -3.75% | 88,471 | 466.30K |
| 46 | BIAF | bioAffinity Technologies, Inc. | 2.63M | -3.75% | 30,051 | 5.90M |